University of Wisconsin Foundation

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), University of Wisconsin Foundation reported 9 stock positions worth $118.1 million. Its top holding was Pearl Diver Credit Compy (PDCC) at 20.4% of the portfolio, followed by Nu Holdings Ltd./Cayman Isl-A (NU, 19.4%) and Akero Therapeutics (AKRO, 13.2%). Compared with Q2 2025, it opened 5 new positions, sold out of 1 and reduced 1. The biggest buy was a new position in Avidity Biosciences (RNAM) and the biggest sale an exit from 89BIO (ETNB).

Most Recent 13F
Q2 2026
Location
MADISON, WI
CIK
0001697228
Portfolio Value
$118.1M (Q3 2025)
SEC Filing
0001697228-25-000019 ↗ filed Nov 14, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $88.6M Q1 2024 Q2 2024: $88.8M Q2 2024 Q3 2024: $153.3M Q3 2024 Q4 2024: $137.6M Q4 2024 Q1 2025: $117.8M Q1 2025 Q2 2025: $89.4M Q2 2025 Q3 2025: $118.1M $118.1M Q3 2025 Q4 2025: $118.9M Q4 2025 Q1 2026: $112.6M Q1 2026 Q2 2026: $126.3M Q2 2026

Holdings 9 stocks · $118.1M

PDCC Pearl Diver Credit Compy Inc. 20.39% 1,459,021 $24.1M No change
NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD 19.41% 1,431,951 $22.9M No change
AKRO Akero Therapeutics Inc. 13.21% 328,504 $15.6M No change
RNAM Avidity Biosciences Inc. 10.67% 289,201 $12.6M New
NVDA Nvidia Corp. 8.70% 55,066 $10.3M New
MSFT Microsoft Corp. 8.52% 19,431 $10.1M New
AAPL Apple Inc. 8.50% 39,402 $10.0M New
DYN Dyne Therapeutics Inc. 5.55% 517,750 $6.5M New
MDGL Madrigal Pharmaceuticals Inc. 5.05% 13,007 $6.0M Reduce -73.1%

Portfolio Sells Q2 2025 → Q3 2025

ETNB 89BIO Inc. Sold out 0.00% −12.67
MDGL Madrigal Pharmaceuticals Inc. Reduce -73.1% 5.05% −11.33

Portfolio Buys Q2 2025 → Q3 2025

RNAM Avidity Biosciences Inc. New 10.67% +10.67
NVDA Nvidia Corp. New 8.70% +8.70
MSFT Microsoft Corp. New 8.52% +8.52
AAPL Apple Inc. New 8.50% +8.50
DYN Dyne Therapeutics Inc. New 5.55% +5.55

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 9$126.3MSMH, CBRS, PDCC, PCVX, NU
Q1 2026 10$112.6MPDCC, NU, PCVX, AAPL, SE
Q4 2025 8$118.9MNU, PDCC, AAPL, NVDA, MSFT
Q3 2025 9$118.1MPDCC, NU, AKRO, RNAM, NVDA
Q2 2025 5$89.4MPDCC, NU, AKRO, MDGL, ETNB
Q1 2025 8$117.8MSE, PDCC, MDGL, NU, AKRO
Q4 2024 7$137.6MSE, PDCC, IVV, NU, MDGL
Q3 2024 7$153.3MSE, IVV, PDCC, NU, AKRO
Q2 2024 6$88.8MIVV, NU, MDGL, GE, AKRO
Q1 2024 6$88.6MIVV, NU, MDGL, GE, AKRO